VYOME HOLDINGS, INC. Fair Value Adjustment of Warrants
VYOME HOLDINGS, INC. (HIND) reported Fair Value Adjustment of Warrants of -$30.51 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-12
- VYOME HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- VYOME HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2025-06-30 was -$66.52K, a 3425.95% decline year-over-year.
- VYOME HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2025-03-31 was $36.01K.
- VYOME HOLDINGS, INC. fair value adjustment of warrants for fiscal 2025 was -$30.51K, a 112.77% decline from fiscal 2024.
- VYOME HOLDINGS, INC. fair value adjustment of warrants for fiscal 2024 was $238.93K.
- VYOME HOLDINGS, INC. fair value adjustment of warrants for fiscal 2023 was -$3.88M.
- VYOME HOLDINGS, INC. fair value adjustment of warrants for fiscal 2021 was $2.81M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | -$66.52K derived: sum of 3 quarters · filed 2026-08-12 | -$30.51K 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$66.52K derived: sum of 2 quarters · filed 2026-08-12 | -$30.51K 10-Q · filed 2025-11-14 | -$31.27K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$66.52K 10-Q · filed 2026-08-12 | -$1.00K 10-Q · filed 2025-08-14 | -$30.51K 10-Q · filed 2026-08-12 | -$3.66M 10-Q · filed 2025-08-14 | -$31.27K derived: sum of 3 quarters · filed 2026-08-12 | $190.42K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | $36.01K 10-Q · filed 2026-05-12 | -$3.66M 10-Q · filed 2025-05-20 | $35.25K derived: sum of 2 quarters · filed 2026-05-12 | $256.94K derived: sum of 3 quarters · filed 2026-05-12 | $258.94K derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | -$755.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $220.94K derived: sum of 2 quarters · filed 2026-03-18 | $222.94K derived: sum of 3 quarters · filed 2026-03-18 | $238.93K 10-K · filed 2026-03-18 | -$52.00K 10-K · filed 2025-04-04 | |||
| 2024-09-30 | $221.69K 10-Q · filed 2025-11-14 | -$27.00K 10-Q · filed 2024-11-14 | $223.69K derived: sum of 2 quarters · filed 2025-11-14 | $239.69K 10-Q · filed 2025-11-14 | -$46.00K 10-Q · filed 2024-11-14 | $174.69K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $2.00K 10-Q · filed 2025-08-14 | $18.00K 8-K · filed 2025-09-02 | -$18.00K 10-Q · filed 2024-08-14 | -$47.00K derived: sum of 3 quarters · filed 2025-08-14 | -$459.00K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$21.00K 10-Q · filed 2025-05-20 | -$49.00K derived: sum of 2 quarters · filed 2025-05-20 | -$461.00K derived: sum of 3 quarters · filed 2025-05-20 | -$933.00K derived: sum of 4 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | -$440.00K derived: sum of 2 quarters · filed 2025-04-04 | -$912.00K derived: sum of 3 quarters · filed 2025-04-04 | -$3.88M 10-K · filed 2025-04-04 | ||||
| 2023-09-30 | -$412.00K 10-Q · filed 2024-11-14 | -$884.00K derived: sum of 2 quarters · filed 2024-11-14 | -$3.85M 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | -$472.00K 10-Q · filed 2024-08-14 | -$3.44M 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$2.96M 10-Q · filed 2024-05-15 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $2.81M 10-K · filed 2023-04-17 | ||||||
| 2021-09-30 | $2.81M 10-Q · filed 2022-11-14 | |||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $0.00 derived: sum of 2 quarters · filed 2018-03-05 | $0.00 derived: sum of 3 quarters · filed 2018-03-05 | $0.00 10-K · filed 2018-03-05 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-03 | $0.00 derived: sum of 2 quarters · filed 2017-11-03 | $0.00 10-Q · filed 2017-11-03 | -$84.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-02 | $0.00 10-Q · filed 2017-08-02 | -$84.00K derived: sum of 3 quarters · filed 2018-03-05 | $585.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | -$84.00K derived: sum of 2 quarters · filed 2018-03-05 | $585.00K derived: sum of 3 quarters · filed 2018-03-05 | $489.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2016-12-31 | -$84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $585.00K derived: sum of 2 quarters · filed 2018-03-05 | $489.00K derived: sum of 3 quarters · filed 2018-03-05 | $466.00K 10-K · filed 2018-03-05 | ||||
| 2016-09-30 | $669.00K 10-Q · filed 2017-11-03 | $573.00K derived: sum of 2 quarters · filed 2017-11-03 | $550.00K 10-Q · filed 2017-11-03 | $553.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2016-06-30 | -$96.00K 10-Q · filed 2017-08-02 | -$119.00K 10-Q · filed 2017-08-02 | -$116.00K derived: sum of 3 quarters · filed 2018-03-05 | -$74.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2016-03-31 | -$23.00K 10-Q · filed 2017-05-10 | -$20.00K derived: sum of 2 quarters · filed 2018-03-05 | $22.00K derived: sum of 3 quarters · filed 2018-03-05 | |||||
| 2015-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $45.00K derived: sum of 2 quarters · filed 2018-03-05 | $34.00K 10-K · filed 2018-03-05 | |||||
| 2015-09-30 | $42.00K 10-Q · filed 2016-11-10 | $31.00K 10-Q · filed 2016-11-10 | ||||||
| 2014-12-31 | -$167.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |